Antagonism of the effects of the hallucinogen dom and the purported 5-HT agonist quipazine by 5-HT2 antagonists
- 1 July 1983
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 91 (2-3), 189-196
- https://doi.org/10.1016/0014-2999(83)90464-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Drug‐induced discrimination: A description of the paradigm and a review of its specific application to the study of hallucinogenic agentsMedicinal Research Reviews, 1983
- DOM-stimulus generalization to LSD and other hallucinogenic indolealkylaminesEuropean Journal of Pharmacology, 1983
- Comparison of behavioral properties of di- and tri-methoxyphenylisopropylaminesPharmacology Biochemistry and Behavior, 1982
- Chapter 1. Biochemical Models for Serotonin ReceptorsPublished by Elsevier BV ,1982
- A BEHAVIOURAL AND BIOCHEMICAL STUDY IN RATS OF 5‐HYDROXYTRYPTAMINE RECEPTOR AGONISTS AND ANTAGONISTS, WITH OBSERVATIONS ON STRUCTURE‐ACTIVITY REQUIREMENTS FOR THE AGONISTSBritish Journal of Pharmacology, 1981
- Two Distinct Central Serotonin Receptors with Different Physiological FunctionsScience, 1981
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Structural relationships in the inhibition of [3H]serotonin binding to rat brain membranes in vitro by 1-phenyl-piperazinesBiochemical Pharmacology, 1980
- Effect of 1-(m-trifluoromethylphenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in vitro and on serotonin turnover in rat brain in vivoEuropean Journal of Pharmacology, 1978
- Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviourNeuropharmacology, 1976